Livengood J R, Sigler T G, Foster L R, Bobst J G, Snider D E
JAMA. 1985 May 17;253(19):2847-9. doi: 10.1001/jama.253.19.2847.
The choice of effective preventive treatment for persons exposed to Mycobacterium tuberculosis resistant to isoniazid is uncertain. Although no data document the efficacy of any drug other than isoniazid for preventive treatment of tuberculosis, rifampin, with or without ethambutol, has been used for prophylaxis in contacts of cases with known isoniazid-resistant organisms. This report describes a community outbreak of isoniazid-resistant tuberculosis infection and a case of rifampin prophylaxis failure with acquired rifampin resistance. This raises concern about the efficacy of rifampin for the preventive treatment of contacts exposed to isoniazid-resistant tuberculosis.
对于接触耐异烟肼结核分枝杆菌的人,选择有效的预防性治疗方法尚无定论。虽然没有数据证明除异烟肼外的任何药物对结核病预防性治疗的疗效,但利福平,无论是否联用乙胺丁醇,已被用于已知有异烟肼耐药菌病例接触者的预防治疗。本报告描述了耐异烟肼结核感染的社区暴发以及一例利福平预防治疗失败并出现获得性利福平耐药的病例。这引发了对利福平预防治疗接触耐异烟肼结核病患者疗效的担忧。